semaglutide and thyroid cancer GLP-1 drugs NOT associated with increased risk of in large medical record database Understanding the Link Between Ozempic

Therapy is ordinarily continued for 12 to 16 weeks before reassessment

Previously approved diabetes drugs were weight neutral or caused weight gain, a concern because obesity is often a co-morbidity of T2DM and can increase the risk for a cardiovascular complication, such as a heart attack or stroke

Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A

Semaglutide mimics a natural hormone (GLP-1) that targets the brain's appetite regulation centers

While CPG new product launches have been in a lull recently, the emerging market demands visionary innovation. Addressing the ripple effects Food retailers, suppliers and manufacturers and restaurant/foodservice operators can mitigate the ripple effects of weight-loss drugs via a number of strategies, according to PwC